Schedule 13D ownership disclosure
VTV THERAPEUTICS INC
Class A Common Stock, par value $0.01 per share · CUSIP: 918385204
Event date: 2025-12-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Samsara BioCapital, L.P.Reported CIK 0001699737
Shares: 246,484.00 · Class: 6.2%
- Samsara BioCapital GP, LLCReported CIK 0001888829
Shares: 246,484.00 · Class: 6.2%
- Samsara Opportunity Fund, L.P.Reported CIK 0002086193
Shares: 152,893.00 · Class: 3.8%
- Samsara Opportunity Fund GP, LLC
Shares: 152,893.00 · Class: 3.8%
- Srinivas AkkarajuReported CIK 0001253170
Shares: 403,942.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001699737-25-000029
- Form type
- SCHEDULE 13D/A
- Filer
- Samsara BioCapital, L.P.
- CIK
- CIK 1699737
- Filed
- Dec 09, 2025
- Reporting period
- Dec 08, 2025
- Description
- Schedule 13D beneficial ownership